Publications (Alphabetical by Author)

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

1. Aisen, P. S., Thal, L. J., Ferris, S. H., Assaid, C., Nessly, M., Guiliani, M. J., Lines, C. R., Norman, B. A., & Potter, W. A. (2008). Rofecoxib in Patients with Mild Cognitive Impairment; Further Analyses of Data from a Randomized, Double-Blind, Trial. Current Alzheimer Research, 5, 73-82

2.   Aisen, P. S., Schneider, L. S., Sano, M., Diaz-Arrastia, R., van Dyck, C. H., Weiner, M. F., Bottiglieri, T., Jin, S., Stokes, K. T., Thomas, R. G., Thal, L. J., & for the Alzheimer Disease Cooperative Study (2008). High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized Controlled Trial. JAMA: the Journal of the American Medical Association, 300, 1774-1783

3.   Apostolova, L. G., Mosconi, L., Thompson, P., Green.A.E., Hwang, K., Ramirez, A., Mistur, R., Tsui, W. H., &  de Leon, M. J. (2008). Subregional hippocampal atrophy predicts Alzheimer's dementia in cognitively normal subjects. Neurobiology of Aging. NIHMS:NIHMS114057

4.   Auclair, U., Epstein, C., & Mittelman, M. (2009). Couples counseling in Alzheimer's disease: Additional clinical findings from a novel intervention study. Clinical Gerontologist, 32, 130-146. NIHMS:NIHMS114897

5.   Auer, S. & Reisberg, B. (2006). Retrogenesis and communication with persons in the severe stages of dementia.  (French translation published as follows): Retrogenese et communication avec les personnes atteintes de demence-severe. Les Cahier de la Fondation Mederic Alzheimer, 2, 126-144

Top of the page

B

6. Boada, M., Tarraga, L., Modinos, G., Diego, S., & Reisberg, B. (2006). Behavioral pathology in Alzheimer's disease Rating Scale (BEHAVE-AD): validacion espanola. Neurologia, 21, 19-25

7.   Boland, B., Kumar, A., Lee, S., Platt, F., Weigel, J., Yu, W. H., & Nixon, R. A. (2008). Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. Journal of Neuroscience, 28, 6926-6937. NIHMS:NIHMS67739

8.   Bruehl, H., Rueger, M., Dziobek, I., Sweat, V., Tirsi, A., Javier E., Arentoft, A., Wolf, O. T., & Convit A. (2007). Cortisol elevations, HPA axis dysregulation, and memory impairments in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 92, 2439-2445
9.   Bruehl, H., Wolf, O. T., & Convit, A. (2009). A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus. Psychoneuroendocrinology. NIHMS:NIHMS114160

10.   Brys, M., Glodzik-Sobanska, L., Switalski, R., Rich, K., Pirraglia, E., Mosconi, L. , De Santi, S., Javier, E., Mehta, P., Zinkowski, R., Pratico, D., Wallin, A., Blennow, K., Sadowski, M., Rusinek, H., & de Leon, M. J. (2008). MRI Improves CSF Biomarkers in the Early Detection of Alzheimer's Disease. Journal of Alzheimer's Disease, 16, 351-362. NIHMS:NIHMS114070

 11.   Brys, M., Mosconi, L., De Santi, S., Rich, K. E., & de Leon, M. J. (2006). CSF Biomarkers for Mild Cognitive Impairment. Aging Health, 2, 111-121

12.   Brys, M., Pirraglia, E., Rich, K., Rolstad, S., Mosconi, L., Switalski, R., Glodzik-Sobanska, L., De Santi, S., Zinkowski, R., Mehta, D., Pratico, D., Saint Louis, L. A., Wallin, A., Blennow, K., & de Leon, M. J. (2009). Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment. Neurobiology of Aging, 30, 682-690. NIHMS:NIHMS107894

Top of the page

C

13.   Carmichael, J. D., Danoff, A., Milani, D., Roubenoff, R., Lesser, M. L., Livote, E., Reitz, R. E., Ferris, S., & Kleinberg, D. L. (2006). GH peak response to GHRH-argenine relation to insulin resistance and other cardiovascular risk factors in a population adults aged 50-90. Clinical Endocrinology, 65, 169-177

14.   Cercy, S. P., Sadowski, M. J., & Wisniewski, T. (2008). Prominent neuroleptic sensitivity in a case of early-onset Alzheimer's disease due to presenilin-1G206A mutation. Cognitive and Behavioral Neurology, 21, 190-195

15.   Choi, S. J., Lim, K. O., Monteiro, I., & Reisberg, B. (2005). Diffusion tensor imaging of frontal white matter microstructure in early Alzheimer's disease: a preliminary study. Journal of Geriatric Psychiatry and Neurology,  18, 12-19

16.   Clark, C. M., DeCarli, C., Mungas, D., Chui, H., Higdon, R., Nunez, J., Fernandez, H., Negron, M., Manly, J., Ferris, S., Perez, A., Torres, M., Ewbank, D., Glosser, G., & van Belle, G. (2005). Earlier onset of Alzheimer disease symptoms in latino individuals compared with anglo individuals. Archives of Neurology, 62, 774-778

17.   Crook, T. H., Ferris, S. H., Alvarez, A., Laredo, M., & Moessler, H. (2005). Effects of N-PEP-12 on memory among older adults. International Clinical psychopharmacology, 20, 97-100

18.   Cummings, J. L., Raman, R., Ernstrom, K., Salmon, D., Ferris, S. H., & for the Alzheimer's Disease Cooperative Study (2006). ADCS Prevention Instrument Project: Behavioral Measures in Primary Prevention Trials. Alzheimer Disease and Associatied Disorders, 20, S139-S149

Top of the page

D

19.   de Leon, M. J., De Santi, S., Zinkowski, R., Mehta, P. D., Pratico, D., Segal, S., Clark, C., Kerkman, D., DeBernardis, J., Li, J., Lair, L., Reisberg, B., Tsui, W., & Rusinek, H. (2004). MRI and CSF studies in the early diagnosis of Alzheimer's disease. Journal of Internal Medicine, 256, 205-223

20.   de Leon, M. J., De Santi, S., Zinkowski, R., Mehta, P. D., Pratico, D., Segal, S., Rusinek, H., Li, J., Tsui, W., Saint Louis, L. A., Clark, C. M., Tarshish, C., Li, Y., Lair, L., Javier, E., Rich, K., Lesbre, P., Mosconi, L., Reisberg, B., Sadowski, M., DeBernadis, J. F., Kerkman, D. J., Hampel, H., Wahlund, L. O., & Davies, P. (2006). Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiology of Aging, 27, 394-401

21.   de Leon, M. J., Mosconi, L., Blennow, K., De Santi, S., Zinkowski, R., Mehta, P. D., Pratico, D., Tsui, W. H., Saint Louis, L. A., Glodzik-Sobanska, L., Brys, M., Li Y., Rich, K. E., Rinne, J. O., & Rusinek, H. (2007). Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. Annals of the New York Academy of Sciences, 1097, 114-145

 22.   de Leon, M. J., Mosconi, L., Li, Y., De Santi, S. , Yao, Y., Tsui, W. H., Pirraglia, E., Rich, K. E., Javier, E., Brys, M., Glodzik-Sobanska, L., Switalski, R., Saint Louis LA, & Pratico, D. (2007). Longitudinal CSF isoprostane and MRI atrophy in the progression to AD . Journal of Neurology, 254, 1666-1675

23.   de Leon, M. J., Mosconi, L., & Logan, J. (2007). Seeing what Alzheimer saw. Nature Medicine, 13, 129-131

24.   De Santi, S., Pirraglia, E., Babb, J., Barr, W., Williams, S., Roger, K.,  Williams, S., Rogers, K., Glodzik, L., Brys, M., Mosconi, L., & Reisberg, B. (2008). robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline. Neuropsychology, 22, 489-484

25.   De Santi, S., Pirraglia, E., Barr, W. B., Babb, J., Williams, S., Rogers, K., Glodzik, L., Brys, M., Mosconi, L., Reisberg, B., Ferris, S., & de Leon, M. J. (2008). Robust and conventional neuropsychological norms: Diagnosis and prediction of age-related cognitive decline. Neuropsychology, 22, 469-484 PMCID:PNC2661242

26.   Devanand, D. P., Liu, X., Tabert, M. H., Pradhaban, G., Cuasay, K., Bell, K., de Leon, M. J., Doty, R. L., Stern, Y., & Pelton, G. H. (2008). Combining Early Markers Strongly Predicts Conversion from Mild Cognitive Impairment to Alzheimer's Disease. Biological Psychiatry, 64, 871-879 PMCID:PMC2613777

27.   Doody, R. S., Ferris, S. H., Salloway, S., Sun, Y., Goldman, R., Watkins, W. E., Xu, Y., & Murthy, A. K. Donezpezil treatment of patients with MCI: A 48-week randomized, placebo-controlled trial. Neurology, (in press)

28.   Drentea, P., Clay, O. J., Roth, D. L., & Mittelman, M. S. (2006). Predictors of improvement in social support: Five-year effects of a structured intervention for caregivers of spouses with Alzehimer's disease. Social Science & Medicine, 63, 957-967

Top of the page

EF

29.       Epstein, C., Auclair, U., & Mittelman, M. (2006). Couples counseling in Alzheimer's disease: First observations of a novel intervention study. Clinical Gerontologist, 30, 21-35.

30.   Falangola, M. F., Jensen, J. H., Babb, J. S., Caixia Hu, M., Castellanos, F. X., Martino, A., Ferris, S. H., & Helpern, J. A. (2008). Age-related non-gaussian diffusion patterns in the prefrontal brain. Journal of Magnetic Resonance Imaging, 1345-1350 PMCID:PMC2669671

31.   Feldman, H., Scheltens, P., Scarpini, E., Herrmann, N., Mesenbrink, P., Mancione, L., Tekin, S., Lane, R., & Ferris, S. (2004). Behavioral symptoms in mild cognitive impairment. Neurology, 1199-1201

32.   Feldman, H. H., Ferris, S., Winblad, B., Sfikas, N., Mancione, L., He, Y., Tekin, S., Burns, A., Cummings, J., del Ser, T., Inzitari, D., Orgogozo, J. M., Sauer, H., Scheltens, P., Scarpini, E., Herrmann, N., Farlow, M., Potkin, S., Charles, H. C., Fox, N. C., & Lane, R. (2007). Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurology, 6, 501-512

33.   Ferris, S., Ihl, R., Robert, P., Winblad, B., Gatz, G., Tennigkeit, F., & Gauthier, S. Severe impairment battery language scale, a language assessment tool for Alzheimer's patients. Alzheimer's & Dementia, (in press).

34.   Ferris, S., Schneider, L., Farmer, M., Kay, G., & Crook, T. (2007). A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI). Int J Geriatr Psychiatry, 22, 448-455

35.   Ferris, S. H. (2006). Supplemental Editorial. Alzheimer Disease and Associated Disorders, 20, S107-S108

36.   Ferris, S. H., Aisen, P. S., Cummings, J., Galasko, D., Salmon, D. P., Schneider, L., Sano, M., Whitehouse, P. J., Edland, S., Thal, L. J., & for the Alzheimer's Disease Cooperative Study (2006). ADCS Prevention Instrument Project: Overview and Initial Results. Alzheimer Disease and Associated Disorders, 20, S109-S123

37.   Fillit, H. M., Doody, R. S., Binaso, K., Crooks, G. M., Ferris, S. H., Farlow, M. R., Leifer, B., Mills, C., Minkoff, N., Burton, O., Reichman, W. E., & Salloway, S. (2006). Recommendations for best practices in the treatment of Alzheimer's Disease in Managed Care. The American Journal of Geriatric Pharmacotherapy, 4, S6-S28

38.   Firuzi, O., Zhuo, J., Chinnici, C. M., Wisniewski, T., & Pratico, D. (2008). 5-Lipoxygenase gene disruption reduces amylod-{beta} pathology in a mouse model of Alzheimer's Disease. Fedration of American societies for Experimental Biology, 22, 1169-1178 PMCID:PMC

Top of the page

G

39.   Galasko, D., Bennett, D. A., Sano, M., Marson, D. , Kaye, J., Edland, S. D., & for the Alzheimer's Disease Cooperative Study (2006). ADCS Prevention Instrument Project: Assessment of Instrumental Activities of Daily Living for Community-dwelling Elderly Individuals in Dementia Prevention Clinical Trials. Alzheimer's Disease and Related Disorders, 20, S152-S169

40.   Gambetti, P., Dong, Z., Yuan, J., Xiao, X., Zheng, M., Alsheklee, A., Castellani, R., Cohen, M., Marder, K., Harris, C., Montine, T., Wisniewski, T., Dickson, D., Hulette, C., DeArmond, SK., Mastrianni, J., Kong, Q., & Zou, W. (2009). A novel human prion disease with protease-sensitive prion. Annals of Neurology, 63, 697-708

41.   Gaugler, J. E., Roth, D. L., Haley, W. E., & Mittelman, M. S. (2008). Can counseling and support reduce burden and depressive symptoms in caregivers of people with Alzheimer's disease during the transition to institutionalization? Results from the New York University Caregiver Intervention Study. Journal of the America Geriatrics Society, 56, 421-428.

42.   Gauthier, S., Reisberg, B., Zaudig, M., Petersen, R. C., Ritchie, K., Broich, K., Belleville, S., Brodaty, H., Bennett, D., Cummings, J., de Leon, M. J., Feldman, H., Ganguli, M., Hampel, H., Scheltens, P., Tierney, M., Whitehouse, P., & Winblad, B. (2006). Mild cognitive impairment. The Lancet, 367 , 1262-1270

43.   Glodzik-Sobanska, L., Li, J., Mosconi, L., Slowik, A., Walecki, J., Szczudlik, A., Sobiecka, B., & de Leon, M. J. (2007). Prefrontal N-acetylaspartate and post-stroke recovery: a longitudinal proton spectroscopy study. American Journal of Neuroradiology, 28, 470-474

44.   Glodzik-Sobanska, L., Pirraglia, E., Brys, M., De Santi, S., Mosconi, L., Rich, K. E. , Switalski, R., Saint Louis, L. A., Sadowski, M., Martiniuk, F., Mehta, P. D., Pratico, D., Zinkowski, R., Blennow, K., & de Leon, M. J. (2009). The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease. Neurobiology Aging, 30,  672-681.

45.   Glodzik-Sobanska, L., Reisberg, B., De Santi, S., Babb, J. S., Pirraglia, E., Rich, K. E., Brys, M., & de Leon, M. J. (2007). Subjective memory complaints: Presence, severity and future outcome in normal older subjects. Dementia and Geriatric Cognitive Disorders, 24, 177-184

46.   Glodzik, L., King, K. G., Gonen, O., Liu, S., De Santi, S., & de Leon, M. J. (2008). Memantine decreases hippocampal glutamate levels:  a magnetic resonance spectrosopy study. Progress in Neuropsychopharmacology and Biological Psychiatry, 1005-1012.

47.   Gnatenko, D. V., Zhu, W., & Bahou, W. F. (2008). Multiplexed genetic profiling of human blood platelets using fluorescent microspheres. Thromb.Haemost., 100, 929-936

48.   Gold, S. M., Dziobek, I., Rogers, K., Bayoumy, A. , McHugh P.F., & Convit A. (2005). Hypertension and HPA axis hyperactivity affect frontal lobe integrity. Journal of Clinical Endocrinology & Metabolism, 90, 3262-3267

49.   Gold, S. M., Dziobek, I., Sweat, V., Tirsi, A., Rogers, K., Bruehl, H., Tsui, W., Richardson, S., Javier, E., & and Convit, A. (2007). Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia, 50, 711-719

50.   Goni, F., Chabalgoity, J. A., Prelli, F., Schreiber, F., Scholtzova, H., Chung, E., Kascsak, R., Brown, D. R., Sirgurdson, E. M., & Wisniewski, T. (2008). High titers of mucosal and systemic anti-PrP antibodies abrogates oral prion infection in mucosal vaccinated mice. Neuroscience, 153, 679-686

51.   Grundman, M., Petersen, R. C., Ferris, S. H., Thomas R.G., Aisen, P. S., Bennett, D. A., Foster, N. L., Jack, C. R., Jr., Galasko, D. R., Doody, R., Kaye, J., Sano, M., Mohs, R., Gauthier, S., Kim, H. T., Jin, S., Schultz, A. N., Schafer, K., Mulnard, R., van Dyck, C. H., Mintzer, J., Zamrini, E. Y., Cahn-Weiner D, & Thal, L. J. (2004). Alzheimer's Disease Cooperative study. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch.Neurol., 61, 59-66

Top of the page

H

52.   Haley, W. E., Bergman, E. J., Roth, D. L., McVie, T., Gaugler, J. E., & Mittelman, M. S. (2008). Long-term effects of bereavement and caregiver intervention on dementia caregiver depressive symptoms. The Gerontogist, 48, 732-740. NIHMS:NIHMS114864

53.   Harvey, P. D., Ferris, S. H., Cummings, J. L., Wesnes, K. A., Hsu, C., Lane, R. M., & Tekin, S. Evaluation of dementia rating scales in Parkinson's Disease Dementia. American Journal of Alzheimer's Disease and Other Dementias, (in press).

Top of the page

IJK

54.   Kamer, A. R., Craig, R. G., Dasanayake, A. P., Brys, M., Glodzik-Sobanska, L., & de Leon, M. J. (2008). Inflammation and Alzheimer's disease: Possible role of periodontal diseases. Alzheimer's and Dementia, 13, 437-449

55.   Khachaturian, Z. S., Petersen, R. C., Gauthier, S., Buckholtz, N., Corey-Bloom, J. P., Evans, B., Fillit, H., Foster, N., Greenberg, B., Grundman, M., Sano, M., Simpkins, J., Schneider, L. S., Weiner, M. W., Galasko, D., Hyman, B., Kuller, L., Schenk, D., Snyder, S.,  Thomas, R. G., Tuszynski, M. H., Vellas, B., Wurtman, R. J., Snyder, P. J., Frank, R. A., Albert, M., Doody, R., Ferris, S., Kaye, J., Koo, E., Morrison-Bogorad, M., Reisberg, B., Salmon, D. P., Gilman, S., Mohs, R., Aisen, P. S., Breitner, J. C. S., Cummings, J. L., Kawas, C., Phelps, C., Poirier, J., Sabbagh, M., Touchon, J., Khachaturian, A. S., & Bain, L. J. (2008). A roadmap for the prevention of dementia: The inaugural Leon Thal Symposium. Alzheimer's and Dementia, 4, 156-163 PMCID:PMC2544623

56.   Khachaturian, Z. S., Work Group A, Snyder, P. J., Chair, Doody, R., Co-Chair, Aisen, P., Comer, M., Dwyer, J., Frank, R. A., Holzapfel, A., Khachaturian, A. S., Korcyzyn, A. D., Phelps, C., Roses, A., Simpkins, J. w., Work Group B:, Schneider, L. S., Chair, Albert, M. S., Co-Chair, E. R., Deves, A., Ferris, S., Greenberg, B. D., Johnson, C., Kukull, W. A. , Poirier, J., Schenk, D., Thies, W., Work Group C, Gauthier, S., Chair, Gilman, S. , Co-Chair, Bernick, C.,  Cummings, J. L., Fillit, H., Grundman, M., Kaye, J., Mucke, L., Reisberg, B., Sano, M., Pickeral, O., Work Group D,  Petersen, R. C., Chair, Mohs, R. C., Co-Chair, Buckholtz, N., Carillo, M., Corey-Bloom, J. P., Foster, N. L., Jacobsen, S., Lee, V., Potter, W. Z., Sabbagh, M. N., Salmon, D., Trajanowski, J. Q., Wexter, N., & Bain L.J. (2009). A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimer's and Dementia, 1-8 PMCID:PMC Journal - In process

57.   King, K. G., Glodzik, L., Liu, S., Babb, J. S., de Leon, M. J., & Gonen, O. (2008). Anterior-to-Posterior Hippocampal Metabolic Heterogeneity: 3D Multivoxel Proton MR Spectroscopic Imaging Initial Findings. Radiology, 249, 242-250

58.   Kluger, A., Gianutsos, J. G., Golomb, J., Wagner, A., Wagner, D., & Scheurich, S. (2007). Clinical changes in MCI:Motor/psychomotor changes. Internationa Psychogeriatrics, 20, 32-39

59.   Kluger, A., Gianutsos, J. G., Golomb, J., Wagner, A., Wagner, D., & Scheurich, S. (2008). Clinical features of MCI: Motor changes. International Psychogeriatrics, 20 , 32-39

60.   Kluger, A. & Golomb, J. (2008). Neuropsychological assessment. In E.A.Capezuti, E. L. Siegler, & M. D. Mezey (Eds.), The Encyclopedia of Elder Care: The comprehensive resource on geriatric social care (2 ed., pp. 554-557). New York: Springer Co.

61.   Kluger, A. & Golomb, J. (2008). Neuropsychological assessment. In E.A.Capezuti, E. L. Siegler, & M. D. Mezey (Eds.), The Encyclopedia of Elder Care: The comprehensive resource on geriatric social care (2 ed., pp. 551-554). New York: Springer and Co.

62.   Klyubin, I., Betts, V., Welzel, A. T., Blennow, K., Zetterberg, H., Wallin, A., Lemere, C. A., Cullen, W. K., Peng, Y., Wisniewski, T., Selkoe, D. J., Anwyl, R., Walsh, D. M., & Rowan, M. J. (2008). Amyloid {beta} Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization. Journal of Neuroscience, 28, 4231-4237. NIHMS:NIHMS60594

Top of the page

L

63.   Lane, R., Feldman, H. H., Meyer, J., He, Y., Ferris, S. H., Nordberg, A., Darreh-Shori, T., Soininen, H. S., Pirttila, T., Farlow, M. R., Sfikas, N., Ballard, C., & Greig, N. H. (2009). Synergistic effect of apolipoprotein E e4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Pharmacogenetics and Genomics, 18, 289-298

64.   Li, Y., Li, J., Segal, S., Wegiel, J., De Santi, S., Zhan, J., Tsui, W. H., Mosconi, L., Rich, K. E., Saint Louis, L. A., & de Leon, M. J. (2006). Hippocampal CSF Spaces on MRI: Relationship to Aging and Alzheimer's disease. Am J Neuroradiol, 27, 912-918

65.   Li, Y., Rinne, J. O., Mosconi, L., Pirraglia, E. , Rusinek, H., De Santi, S., Kemppainen, N., Nagren, K., Kim, B. C., Tsui, W., & de Leon, M. J. (2008). Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment and Alzheimer's disease. European Journal Of Nuclear Medicine And Molecular Imaging, 35, 2169-2181. NIHMS:NIHMS114119

66.   Liang, Z., Liu, F., Iqbal, K., Grundke-Iqbal, I., Weigel, J., & Gong, C.-X. (2008). Decrease of protein phosphatase 2A and its association with accumulation and hyperphosphorilation of tau in Down syndrome. Journal of Alzheimer's Disease, 13, 295-302 PMCID:PMC2655351

67.   Liu, F., Liang, Z., Weigel, J., Hwang, Y. W., Iqbal, K., Grundke-Iqbal, I., Ramakrishna, N., & Gong, C.-X. (2008). Overexpression of Dyrk1A contributes to neurofibilary degenration in Down syndeome. Federation of American Societies for Experimental Biology, 22, 3224-3233 PMCID:PMC2518253

Top of the page

MNO

68.   Meyer, M., Mittelman, M. S., & Epstein, C. (2008). The comfort of home, Alzheimer's edition: A guide for caregivers. San Francisco: CareTrust Publications.

69.   Mikheev, A., Nevsky, G., Yitta, S., Grosmann, R., & Rusinek, H. (2008). Fully automated segmentation of the brain from T1-weighted MRI using Bridge Burner algorithm. Journal of Magnetic Resonance Imaging, 27, 1235-1241. NIHMS:NIHMS114439

70.   Milani, D., Carmichael, J. D., Welkowitz, J., Ferris, S., Reitz, R. E., Danoff, A., & Kleinberg, D. L. (2004). Variability and reliability of single serum IGF-1 measurements: Impact on determining predictability or fisks ratios in disease development. Journal of Clinical Endocrinology & Metabolism, 89, 2271-2274

71.   Milani, D., Carmichael, J. D., Welkowitz, J., Ferris, S., Reitz, R. E., Danoff, A., & Kleinberg, D. L. (2006). Variability and Reliability of Single Serum IGF-I Measurements: Impact on Determining Predictability of Risk Ratios in Disease Development. The Journal of Clinical Endocrinology & Metabolism, 89, 2271-2274

72.   Mittelman, M. S. (2008). Psychosocial intervention research: Challenges, strategies and measurement issues. Aging & Mental Health, 12, 1-4

73.   Mittelman, M. S., Brodaty, H., Wallen, A. S., & Burns, A. (2008). A three country randomized controlled trial of a psychosocial intervention for caregivers combined with pharmacological treatment for patients with Alzheimer disease: Effects on caregiver depression. American Journal of Geriatric Psychiatry,  16, 893-904. NIHMS:NIHMS113830

74.   Mittelman, M. S., Roth, D. L., Clay, O., & Haley, W. E. (2007). Preserving health of Alzheimer's caregivers: Impact of a spouse caregiver intervention. American Journal of Geriatric Psychiatry, 15, 780-789

75.   Morris, J. C., Weintraub, S., Chui, H. C., Cummings, J., DeCarli, C., Ferris, S. H. , Foster, N. L., Galasko, D., Graff-Radford, N., Peskind, E. R., Beekly, D., Ramos, E. M., & Kukull, W. A. (2006). The Uniform Data Set (UDS): Clinical and Cognitive variables and Descriptive Data from Alzheimer Disease Centers. Alzheimer Disease & Associated Disorders, 20, 210-216

76.   Mosconi L., pupi, Pupi, A., De Cristofaro, M. T., Fayyaz, M., Sorbi, S., & Herholz, K. (2004). Functional Interactions of the Entorhinal Cortex: An 18F-FDG PET Study on Normal Aging and Alzheimer's Disease. The Journal of Nuclear Medicine, 45, 382-392

77.   Mosconi, L. (2005). Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. Eur J Nucl Med, 32, 486-510

78.   Mosconi, L., Brys, M., Glodzik-Sobanska, L., De Santi, S., Rusinek, H., & de Leon, M. J. (2007). Early detection of Alzheimer's disease using neuroimaging. Experimental Gerontology,  42, 129-138

79.   Mosconi, L., Brys, M., Switalski, R., Mistur, R., Glodzik-Sobanska, L., Pirraglia, E. , Tsui, W. H., De Santi, S., & de Leon, M. J. (2007). Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proceedings of the National Academy of Sciences USA, 104, 19067-19072 PMCID:PMC2141909

80.   Mosconi, L., De Santi, S., Brys, M., Tsui, W. H., Pirraglia, E., Glodzik-Sobanska, L. , Rich, K. E., Switalski, R., Mehta, P. D., Pratico, D., Zinkowski, R., Blennow, K., & de Leon, M. J. (2008). Hypometabolism and altered CSF markers in normal ApoE E4 carriers with subjective memory complaints.  Biol Psychiatry, 63, 609-618 PMCID:PMC236268

81.   Mosconi, L., De Santi, S., Li, J., Tsui, W. H., Li, Y., Boppana, M., Rusinek, H., & de Leon, M. J. (2008). Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiology of Aging, 29, 676-692 PMCID:PMC2430185

82.   Mosconi, L., De Santi, S., Li, Y., Li, J., Zhan, J., Tsui, W. H., Boppana, M., Pupi, A., & de Leon, M. J. (2006). Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET. European Journal of Nuclear Medicine, 33, 210-221

83.   Mosconi, L., De Santi, S., Rusinek, H., Convit, A., & de Leon, M. J. (2004). Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease. Expert Review of Neurotherapeutics, 4, 831-849

84.   Mosconi, L., Herholz, K., Prohovnik, I., Sorbi, S., Nacmias, B., De Cristofaro, M. T. R., Fayyaz, M., Bracco, L., & Pupi, A. (2005). Metabolic interaction between APOE genotype and onset age in Alzheimer disease.  Implications for brain reserve. Journal of Neurology, Neurosurgery, and Psychiatry, 76, 15-23

85.   Mosconi, L., Mistur, R., Glodzik, L., Brys, M., Switalski, R., Pirraglia, E., Rich, K., Tsui, W., De Santi, S., & de Leon, M. J. (2009). Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer's. Neurology, 72, 513-520. NIHMS:NIHMS114157

86.   Mosconi, L., Mistur, R., Switalski, R., Tsui, W., Glodzik, L., Brys, M., Li, Y., Pirraglia, E., De Santi, S., Reisberg, B., Wisniewski, T., & de Leon, M. J. (2008). FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. European Journal Of Nuclear Medicine And Molecular Imaging, 36, 811-822 PMCID:PMC Journal - In process

87.   Mosconi, L., Nacmias, B., Sorbi, S., De Cristofaro, M., Fayazz, M., Tedde, A., Bracco, L., Herholz, K., & Pupi, A. (2004). Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease. Journal of Neurology, Neurosurgery & Psychiatry, 370-376

88.   Mosconi, L., Perani, D., Sorbi, S., Herholz, K., Nacmias, B., Holthoff, V., Salmon, E., Baron, J.-C., De Cristofaro, M. T. R., Padovani, A., Borroni, B., Franceschi, M., Bracco, L., & Pupi, A. (2004). MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology, 63, 2332-2340

89.   Mosconi, L., Pupi, A., & de Leon, M. J. (2009). Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's Disease. Annals of the New York Academy of Sciences, 1147, 180-195

90.   Mosconi, L., Sorbi, S., de Leon, M. J., Li, Y., Nacmias, B., Bessi, V., Tsui, W. H., Myoung, P. S., Fayyaz, M., Caffarra, P., & Pupi, A. (2006). Hypometabolism exceeds atrophy in presymptomatic early-onset Familial Alzheimer's disease. Journal of Nuclear Medicine, 47, 1778-1786

91.   Mosconi, L., Sorbi, S., Nacmias, B., De Cristofaro, M. T., Fayyaz, M., Bracco, L., Herholz, K., & Pupi, A. (2004). Age and ApoE genotype interaction in Alzheimer's disease: an FDG-PET study. Psychiatry Research: Neuroimaging, 130, 141-151

92.   Mosconi, L., Tsui, W. H., De Santi, S., Rusinek, H., Li, J., Convit, A., Li, Y., & de Leon, M. J. (2005). Reduced hippocampal metabolism in mild cognitive impairment and Alzheimer's disease: automated FDG-PET image analysis. Neurology, 64, 1860-1867

93.   Mosconi, L., Tsui, W. H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., Reiman, E. M., Holthoff, V., Kalbe, E., Sorbi, S., Diehl-Schmid, J., Perneczky, R., Clerici, F., Caselli, R. J., Beuthien-Beumann, B., Kurz, A., Minoshima, S., & de Leon, M. J. (2008). Multi-center standardized FDG-PET diagnosis of Mild Cognitive Impairment, Alzheimer's disease and other dementias. Journal of Nuclear Medicine, 49, 390-398. NIHMS:NIHMS114120

94.   Myers, C. E., Kluger, A., Golomb, J., Gluck, M., & Ferris, S. (2008). Learning generalization tasks predict short-term cognitive outcome in nondemented elderly. Journal of Geriatric Psychiatry and Neurology, 21, 93-103

95.   Olazaran, J., Muniz, R., Reisberg, B., Pena-Casanova, J., del Ser, T., Cruz-Jentoft, A. J., Serrano, P., Navarro, E., de la Rocha, G., Frank, A., Galiano, M., Fernandez-Bullido, Y., Serra, J. A., Gonzalez-Salvador, M. T., & Sevilla, C. (2004). Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease. Neurology, 63, 2349-2353

Top of the page

PQ

96.   Patterson, M. B., Whitehouse, P. J., Edland, S. D., Sami, S. A., Sano, M., Smyth, K., Weiner, M. F., & for the Alzheimer's Disease Cooperative Study (2006). ADCS Prevention Instrument Project: Quality of Life Assessment (QOL). Alzheimer Disease & Associated Disorders, 20, S179-S190

97.   Peisah, C., Finkel, S., Shulman, K., Melding, P., Luxenberg, J., Heinik, J., Jacoby, R., Reisberg, B., Stoppe, G., Barker, A., Firmino, H., Bennett, H., & for the International Psychogeriatric Association Task Force on wills and Undue Influence (2009). The wills of older people: risk factors.  International Psychogeriatrics, 21, 7-15

98.   Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S. H., Galasko, D., Jin, S., Kaye, J., Levey, A., Pfeifer, E., Sano, M., van Dyck, C. H., Thal, L. J., & for the Alzheimer's Disease Cooperative Study (2005). Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment. The New England Journal of Medicine, 352, 23789-2388

99.   Prichep, L. S., John, E. R., Ferris, S. H., Rausch, L., Fang, Z., Cancro, R., Torrosian, C., & Reisberg, B. (2006). Prediction of longitudinal cognitive decline in normal elderly with subjective complaints using electrophysiological imaging. Neurobiology of Aging, 27, 471-481

Top of the page

R

100. Reisberg, B. (2005). Commentary on "Diagnosis of Alzheimer's disease: Two decades of progress ."Symptomatology and biomolecular basis of Alzhemer's: A synthesis. Alzheimer's & Dementia, 1, 102-106

101.   Reisberg, B. (2006). Diagnostic criteria in dementia: A comparison of current criteria, research challenges and implications for DSM-V. Journal of Geriatric Psychiatry & Neurology, 19, 137-146

102.   Reisberg, B. (2007). Global Measures:Utility in defining and measuring treatment response in dementia. International Psychogeriatrics, 19, 421-456

103.   Reisberg, B., Doody, R., Stoffler, A., Schmitt, F., Ferris, S., & Mobius, H.-J. (2006). A 24-week open-label extension study of Memantine in moderate to severe Alzheimer Disease. Archives of Neurology, 63, 49-54

104.   Reisberg, B. & Ferris, S. H. (2004). Clinician's interview-based impression of change-plus. In C.Kelly & G. Newton-Howes (Eds.), Guide to Assessment Scales in Dementia (pp. 9-10). London, UK: Science Press Ltd.

105.   Reisberg, B., Ferris, S. H., Kluger, A., Franssen, E., Wegiel, J., & de Leon, M. J. (2008). Mild cognitive impairment (MCI): A historical perspective. Int Psychogeriatr., 20, 18-31

106.   Reisberg, B. & Gauthier, S. (2008). Current evidence for subjective cognitive impairment (SCI) as a pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. International Psychogeriatrics, 20, 1-16

107.   Reisberg, B., Javed, A., Kenowski, S., & Auer, S. R. (2005). Alzheimer's disease. In: Medical Aspects of Disability, 3rd Edition. In (pp. 79-118).

108.   Reisberg, B., Prichep, L., Mosconi, L., John, E. R., Glodzik-Sobanska, L., Boksay, I., Monteiro, I., Torossian, C., Vedvyas, A., Ashraf, N.,  Jamil, I. A., & de Leon, M. J. (2008). The pre-Mild Cognitive Impairment, Subjective Cognitive Impairment stage of Alzheimer's disease. Alzheimer's & Dementia, 4, S98-S108

109.   Reisberg, B. & Sartorius, N. (2007). Diagnostic criteria in dementia:A comparison of current criteria, research challenges, and implications for DSM-V. In Diagnostic Issues in Dementia: Advancing the Research Agenda for DSM-V,T. American Psychiatric Association, 27-50

110.   Reisberg, B. & Sartorius, N. (2009). Diagnostic criteria in dementia: A comparison of current criteria, research challenges, and implications for DSM-V. In: Diagnostic issues in Dementia: Advancing the Research Agenda  for DSM-V. In T.Sunderland, D. V. Jeste, O. Baiyewu, P. Sirovatka, & D. A. Reiger (Eds.), ( Washington (DC).

111.   Reisberg, B., Sclan, S., Franssen, E., de Leon, M. J., Kluger, A., Torossian, C., Shulman, E., Steinberg, G., Monteiro, I., McRae, T., Boksay, I., Mackell, J., & Ferris, S. H. (2008). The GDS Staging System: Global Deterioration Scale (GDS), Brief Cognitive Rating Scale (BCRS), functional Assessment Staging (FAST). In A.J.Rush, Jr., M. B. First, & D. Blacker (Eds.), Handbook of Psychiatric Measures (2nd ed., pp. 431-435). Washington, D.C.: American Psychiatric Publishing.

112.   Reisberg, B. & Shulman, M. B. "A Roadmap for the Prevention of Demnetia II:Leon Thal Symposium 2008" Subjective cognitive impairment as in antecedent of Alzheimer's dementia. Alzheimer's & Dementia, (in press)

113.   Reisberg, B. & Shulman, M. B. (2009). Commentary on "A roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Subjective cognitive impairment as an antecedent of Alzheimer's dementia: Policy import. Alzheimer's and Dementia, 5, 154-156

114.   Reisberg, B., Weigel, J., Franssen, E., Auer, S. , Shimada, M., Meguro, K., Kadiyala, S., & Borza, L. (2006). Behavioral and neuropathophysiologic course of Alzheimer's disease (AD): A synthesis based on retrogenisis, arboreal and neurometabolic entropy and possible etiopathogenic events. In K.Iqbal, B. Winblad, J. Avila, & Bologna (Eds.), Alzheimer's Disease (pp. 219-222).

115.   Reisberg, B., Weigel, J., Franssen, E., Kadiyala, S., Auer, S., Souren, L., Sabbagh, M., & Golomb, J. (2006). Clinical features of severe dementia: staging.In: Severe Dementia. In A.Burns & Winblad B. (Eds.), (pp. 83-115). London, John Wiley& sons.

116.   Reiss, A. B., Siller, K. A., Rahman, M. M., Chan, E. S. L., Ghiso, J., & de Leon, M. J. (2004). Cholesterol in neurological disorders of the elderly: stroke and Alzheimer's disease. Neurobiology of Aging, 25, 977-989

117.   Rusinek, H., Endo, Y., De Santi, S., Frid, D., Tsui, W. H., Segal, S., Convit, A., & de Leon, M. J. (2004). Atrophy rate in medial temporal lobe during progression of Alzheimer disease. Neurology, 63, 2354-2359

Top of the page

S

118.   Sabbagh, M. N., Lathi, T., Connor, D. J., Caviness, J. N., Shill, H., Mahant, P., Samanta, J., Burns, R. S.,  Evidente, V. G. H., Driver-Dunckley, E., Reisberg, B., Bircea, S., & Adler, C. H. (2007). Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease. Dement Geriatr Cogn Disord, 13, 1943-1954

119.   Sabbagh, M. N., Silverberg, N., Bircea, S., Majeed, B., Samant, S., Caviness, J. N., Reisberg, B., & Adler, C. H. (2005). Is the functional decline in Parkinson's disease similar to the functional decline of Alzheimer's disease? Parkinsonism and Related Disorders, 11, 311-315

120.   Sadowski MJ, Pankiewicz J, Prelli F, Scholtzova H, Spinner DS, Kascsak RB, Kascsak RJ, & Wisniewski T.  Anti-PrP Mab 6D11 suppresses PrP replication in prion infected myeloid precursor line FDC-P1/22L and lymphoreticular system in vivo. Neurobiology of Disease, (in press)

121.   Sadowski, M., Verma, A., & Wisniewski, T. (2004). Infectious Disease of the Nervous System: Prion Diseases. In W.G.Bradley, R. B. Daroff, G. M. Fenichel, & J. Jankovic (Eds.), Neurology in Clinical Practice (pp. 1567-1581). Butterworth-Heinemann (Elsevier).

122.   Sadowski, M., Verma, A., & Wisniewski, T. (2009). Infections of the Nervous System:Prion Diseases. In Neurology in Clinical Practice (5th Edition ed., pp. 1567-1581).

123.   Sadowski, M. & Wisniewski, T. (2007). Disease modifying approches for Alzheimer's pathology. Current Pharmaceutical Design, 13, 1943-1954

124.   Sadowski, M. J., Pankiewicz, J., Prelli, F., Scholtzova, H., Spinner, D. S., Kascsak, R. B., Kascsak, R. J., & Wisniewski, T. (2009). Anti-PrP Mab 6D11 suppresses PrPSc replication in prion infected myeloid precursor line FDC-P1/22L and in the lymphoreticular system in vivo. Neurobiology of Disease, 34, 267-278

125.   Salmon, D. P., Cummings, J. L., Jin, S., Sano, M., Sperling, R. A., Zamrini, E., Petersen, R. C., Edland, S. D., Thal, L. J., Ferris, S. H., & for the Alzheimer's Disease Cooperative Study (2006). ADCS Prevention Instrument Project: Development of a Brief Verbal Memory Test for Primary Prevention Clinical Trials. Alzheimer Disease and Associatied Disorders, 20, S139-S146

126.   Sano, M., Zhu, C. W., Whitehouse, P. J., Edland, S., Jin, S., Ernstrom, K., Thomas, R. G., Thal, L. J., Ferris, S. H., & for the Alzheimer's Disease Cooperative Study (2006). ADCS Prevention Instrument Project: Pharmacoeconomics: Assessing health related resource use among healthy elderly. Alzheimer Disease and Associated Disorders, 20, S191-S202

127.   Schneider, L. S., Clark, C. M., Doody, R., Ferris, S. H., Morris, J. C., Raman, R., Reisberg, B., & Schmitt, F. A. (2006). ADCS Prevention Instrument Project: ADCS-Clinicians' Global Impression of Change Scales (ADCS-CGIC), Self-Rated and Study Partner-Rated Versions. Alzheimer Disease and Associated Disorders, 20, S124-S138

128.   Schneider, L. S., Raman, R., Schmitt, F. A., Doody, R., Unsel, P., Clark, C. M., Morris, J. C., Reisberg, B., Petersen, R. C., & Ferris, S. H. Characteristics and performance of a modified version of the ADCS-CGIC CIBIC + for mild cognitive impairment clinical trials. Alzheimer Disease and Associated Disorders, (in press).

129.   Scholtzova, H., Wadghiri, Y. Z., Douadi, M., Sigurdsson, E. M., Li, Y.-S., Quartermain, D., Banerjee, P., & Wisniewski, T. (2008). A NMDA receptor antagonist leads to behavioral improvement and amyloid reduction in Alzheimers disease model transgenic mice shownby miromagnetic imaging. Journal of Neuroscience Research, 86, 2784-2791

130.   Shi, J., Zhang, T., Zhou, C., Chohan, M. O., Gu, X., Weigel, J., Zhou, J., Hwang, Y. W., Iqbal, K., Grundke-Iqbal, I., Gong, C.-X., & Liu, F. (2008). Increased dosage of Dyrk1A alters alternative splicing factor (ASF) regulated alternative splicing of tau in Down syndrome. Journal of Biological.Chemistry, 283, 28660-28669 NP,C,d,t

131.   Sigurdsson, E. M., Wadghiri, Y. Z., Mosconi, L., Blind, J. A., Knudsen, E., Asuni, A., Scholtzova, H., Tsui, W. H., Li, Y., Sadowski, M., Turnbull, D. H., de Leon, M. J., & Wisniewski, T. (2008). A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice. Neurobiology of Aging, 29, 836-847 PMCID:PMC2408732

132.   Spinner, D. S., Cho, I. S., Park, S. Y., Kim, J. I., Meeker, H. C., Ye, X., LaFauci, G., Kerr, D. J., Flory, M. J., Kim, B.-S., Kascsak, R. B., Wisniewski, T., Levis, W. R., Schuller-Levis, G. B., Carp, R. I., Park, E., & Kascsak, R. B. (2008). Accelerated prion disease pathogenesis in the absence of Toll-like receptor 4(TLR4) signaling. Journal of Virology, 82, 10701-10708 PMCID:PMC2573175

133.   Su, Z., Hu, J., & Zhu, W. (2008). Multi-Step Variance Minimization in Sequential Tests. Statistics and Computing, 18, 101-108

134.   Sweat, V., Starr, V., Bruehl, H., Arentoft, A., Tirsi, A., Javier E., & Convit, A. (2008). C-Reactive Protein is Linked to Lower Cognitive Performance in Overweight and Obese Women. Inflammation, 31, 198-207

135.   Sweat, V., Starr, V., Bruehl, H., Arentoft, A., Tirsi, A., Javier, E., &  Convit, A. (2008). C-Reactive Protein is Linked to Lower Cognitive Performance in Overweight and Obese Women. Inflammation, 31, 198-207

Top of the page

TUV

136.   Thal, L. J., Ferris, S. H., Kirby, L., Block, G. A., Lines, C. R., Yuen, E., Assaid, C., Nessly, M. L., Norman, B. A., Baranak, C. C., & Reines, S. A. (2005). Rofecoxib Protocol 078 study group. A randomized, double blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology, 30, 1204-1215

137.   Tirsi, A., Bruehl, H., Tsui, W., Reddy, S., Sweat, V., Starr, V., Lee, C., & Convit, A. (2009). Retinal Vessel Abnormalities are Associated with Elevated Fasting Insulin Levels and Cerebral Atrophy in Non-Diabetic Individuals. Ophthalmology, In Press. NIHMS:NIHMS114164

138.   Trouche, S. G., Asuni, A., Rouland, S., Wisniewski, T., Frangione, B., Verdier, J. M., Sirgurdson, E. M., & Mestre-Frances, N. (2009). Antibody response and plasma A beta 1-40 in young Microcebus Murinus primates immunized with A beta 1-42 and its derivates. Vaccine, 27, 957-964

Top of the page

W

139. Walsh, S. P., Raman, R., Jones, K. B., Aisen, P. S., & for the Alzheimer's Disease Cooperative Study (2006). ADCS Prevention Instrument Project: The Mail-In Cognitive Function Screening Instrument (MCFSI). Alzheimer Disease & Associated Disorders, 20, S170-S178

140.   Wegiel, J., Kuchna, I., Nowicki, K., Frackowiak RSJ, Mazur-Kolecka, B., Imaki, H., Mehta, PD., Silverman, W., Reisberg, B., de Leon MJ., Wisniewski, T., Pirttila, T., Frey H, Lehtimaki, T., Kivimaki, T., Visser FE, Kamphorst, W., Potempska, A., Bolton, D., Currie JR, & Miller DL (2007). Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration. Acta Neuropathol, 113, 389-402

141.   Wegiel, J., Kuchna, I., Novicki, K., Dowjat, W., Reisberg, B., de Leon, M. J., Wisniewski, T., Chen-Hwang, M. C., & Hwang, Y. W. (2004). Cell type and brain structure-specific patterns of distribution of minibrain kinase in human brain. Brain Research, 1010, 69-80

142.   Weigel, J., Dowjat, W. K., Kaczmarski, W., Kuchna, I., Nowicki, K., Frackowiak, J., Kolecka, B. M., Wegiel, J., Mazur Kolecka, B., Weigel, J.,  Silverman, W. P., Reisberg, B., de Leon, M. J., Wisniewski, T., Gong, C.-X., Liu, F., Adayev, T., Chen-Hwang, M. C., & Hwang, Y. W. (2008). The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome. Acta Neuropathologica, 116, 391-407 PMCID:PMC2656568

143.   Whitehouse, P. J., Rajcan, J. L., Sami, S. A., Patterson, M. B., Smyth, K. A., Edland, S. D., & George, D. R. (2006). ADCS Prevention Instrument Project: Pilot Testing of a Book Club as a Psychosocial Intervention and Recruitment and Retention Strategy. Alzheimer's Disease and Associated Disorders, 20, S203-S208

144.   Wisniewski, T. & Konietzko, U. (2008). Amyloid beta immunization for Alzheimer's disease. Lancet Neurology, 7, 805-811

145.   Wisniewski, T. & Sadowski, M. (2008). Preventing A beta fibrilization and deposition: beta sheet breakers and pathological chaperone inhibitors. BMC.Neuroscience, 9,  1-5 PMCID:PMC2604889

146.   Wolf, O. T., Dziobek, I., McHugh, P. F., Sweat, V., de Leon, M. J., Javier, E., & Convit, A. (2005). Subjective memory complaints in aging are associated with elevated cortisol levels. Neurobiology of Aging, 10, 1357-1363

147.   Wong, W. K. & Zhu, W. (2008). Optimum Treatment Allocation Rules under a Variance Heterogeneity Model. Statistics in Medicine, 27, 4581-4595

Top of the page

XYZ

148.   Zamrini, E., De Santi, S., & Tolar, M. (2004). Imaging is superior to cognitive testing for early diagnosis of Alzheimer's disease. Neurobiology of Aging, 25, 685-691

149.   Zhan, J., Brys, M., Glodzik-Sobanska, L., Tsui, W., Javier, E., Wegiel, J., Kuchna, I., Pirraglia, E., Li, Y., Mosconi, L., Saint Louis, L. A., Switalski, R., De Santi, S., Wisniewski, T., Bobinski, M., & de Leon, M. J. (2009). Entorhinal cortex sulcal pattern is associated with Alzheimer's disease. Human Brain Mapping, 30, 874-882.

Top of the page